Page 7 - CUA2019 Abstracts - Oncology-Kidney
P. 7

2019 CUA Abstracts





        rosis, and arteriolar changes. Patients undergoing nephrectomy at our   UP-9.8
        centre were identified and included. Exclusion criteria included: loss   Impact of time-to-surgery and surgical delay on oncological
        to followup, obstructive nephropathy, preoperative end-stage renal dis-  outcomes for renal cell carcinoma
        ease, and bilateral nephrectomies. Patient demographics were described   Benjamin Shiff , Rodney H. Breau , Premal Patel , Anil Kapoor , Frédéric
                                                                                    2
                                                                                                        4
                                                                       1
                                                                                              3
        using descriptive statistics. Multivariate logistic regression models were   Pouliot , Alan I. So , Ricardo A. Rendon , Ronald B. Moore , Antonio
                                                                  5
                                                                                          7
                                                                                                        8
                                                                           6
        created to assess the effect of NNK and other clinical factors on renal   Finelli , Simon Tanguay , Luke T. Lavallée , Jean-Baptiste Lattouf , Jun
                                                                                                           11
                                                                                           2
                                                                 9
                                                                              10
        function.                                            Kawakami , Daniel Heng , Ranjeeta Mallick , Darrel E. Drachenberg 1
                                                                               12
                                                                                             13
                                                                    12
        Results: Sixty-three of 101 patients were deemed eligible for statistical   1 Urology, University of Manitoba, Winnipeg, MB, Canada;  Urology,
                                                                                                        2
        analysis at one year; 70% had a radical nephrectomy and the remainder   University of Ottawa, Ottawa, ON, Canada;  Urology, University of Miami,
                                                                                           3
        had a partial nephrectomy. The mean age and tumour size for patients   Miami, FL, United States;  Urology, McMaster University, Hamilton,
                                                                                4
        were 62 years and 5.5 cm, respectively. History of smoking, hypertension,   ON, Canada;  Surgery, Université Laval, Québec City, QC, Canada;
                                                                        5
        and diabetes was present in 38%, 43%, and 11%, respectively. Twenty   6 Urologic Sciences, University of British Columbia, Vancouver, BC,
        percent of patients had CKD stage 3 or greater at baseline vs. 57% after   Canada;  Urology, Dalhousie University, Halifax, NS, Canada;  Urology,
                                                                   7
                                                                                                        8
        one year. Mean estimated glomerular filtration rate (eGFR) prior to surgery   University of Alberta, Edmonton, AB, Canada;  Urology, University of
                                                                                               9
        was 68, while at one year it was reduced to 55. Glomerular sclerosis   Toronto, Toronto, ON, Canada;  Urology, McGill University, Montréal,
                                                                                   10
        severity on NNK assessment was predictive of decline in renal function   QC, Canada;  Surgery, Université de Montréal, Montréal, QC, Canada;
                                                                       11
        and rise in serum creatinine. Having had a radical procedure and high   12 Medical Oncology, University of Calgary, Calgary, AB, Canada;  Ottawa
                                                                                                         13
        glomerular sclerosis score was associated with CKD stage progression   Hospital Research Institute, Ottawa, ON, Canada
        and thus renal function deterioration.               Introduction: Surgical wait times (SWT) are a major concern in health-
        Conclusions: This study demonstrated that NNK evaluation can be helpful   care. In 2005, the Canadian Surgical Wait Time Consensus statement
        in identifying patients who are at risk for the development or progres-  suggested wait times of <90 days for T1a and <28 days for ≥T1b asymp-
        sion of CKD.                                         tomatic renal masses.  Few reports have examined the effect of prolonged
                                                                            1
                                                             SWT for renal cancer surgery on oncological outcomes and those that
        UP-9.7                                               exist were conducted on a single-institution level. We aimed to evaluate
                                                                                               2-4
        Management of small renal masses: Identifying barriers to the   whether SWT is associated with treatment outcomes for renal masses on
        use of renal tumour biopsy and interventions to optimize its   a multi-institution level.
        use in Ontario                                       Methods: The Canadian Kidney information system (CKCis) is a national
        Ranko Savic , Anna R. Gagliardi , Shabbir M. Alibhai , Lisa Martin , Maria   multi-institution database of patients with kidney tumours. This database was
                              2
                1
                                            3
                                                    1
        Komisarenko , Patrick Richard , Antonio Finelli 1    used to identify a historical cohort of patients who underwent surgery for ≥
                 1
                             4
        1 Princess Margaret Cancer Centre, University Health Network and   clinical stage T1b renal cell carcinoma (RCC) from 2011 onwards. Time from
        University of Toronto, Toronto, ON, Canada;  Toronto General Hospital   final imaging prior to surgery to the date of surgery was used as a measure of
                                        2
        Research Institute, University Health Network and University of Toronto,   SWT. Oncological outcomes, such as recurrence-free survival (RFS), cancer-
        Toronto, ON, Canada;  Department of Medicine, University Health Network   specific survival (CSS), and overall survival (OS) were stratified by clinical
                       3
        and University of Toronto, Toronto, ON, Canada;  Faculty of Medicine and   stage and SWT to assess for associations between SWT and outcomes.
                                         4
        Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada  Results: Of 1395 patients included in the analysis, 664 (47.6%) were
        Introduction: Despite having high performance and low complication   categorized as stage cT1b, 387 (27.7%) as stage cT2, and 344 (24.7%)
        rates, renal tumuor biopsy (RTB) is underused in Canada. Some bar-  as stage cT3/4. Mean followup duration was 28.80 months. Mean SWT
        riers to the use of RTB have been previously identified using surveys.   was 61.6 days, 39.3 days, and 31.5 days for stages cT1b, cT2, and cT3/4,
        This study used open-ended interviews in Ontario to examine barriers   respectively. Among cT1b, cT2, and cT3/4 patients, SWT exceeded 12
        and facilitators to the use of RTB, and identify potential interventions to   weeks in 27.4%, 11.6%, and 8.1% of patients, respectively. There was no
        overcome the barriers.                               association between SWT and RFS, margin status, or lymph node status
        Methods: Recruitment packages were mailed to all currently active urolo-  for tumours of all clinical stages.
        gists in Ontario (n=307) using contact information from the publicly avail-  Conclusions: Mean SWTs for renal cancer surgery appear to be within
        able Canadian Physicians and Surgeons of Ontario database. Followup   recommendations, although a significant proportion of cT1b patients are
        recruitment packages were sent two weeks later. Semi-structured, open-  experiencing prolonged wait times. Patients who had longer SWTs in this
        ended telephone interviews were conducted with urologists who agreed   study did not experience negative oncological outcomes, such as positive
        to participate. Interviews were audio-recorded and transcribed verbatim.   margins, positive lymph nodes, or worse RFS among all clinical stages.
        Themes were identified using a basic descriptive qualitative approach.  References
        Results: Twenty-four urologists were interviewed (response rate 8%).   1.   Aprikian A,  Bagnell  S,  Bell  D,  et  al.  Consensus  document:
        Participants were from academic (n=12) and community (n=12) hospital   Recommendations for optimal surgical wait times for patients with
        settings. The main themes for RTB barriers were clinician barriers, RTB   urological malignancies. Can J Urol 2006;13Suppl 3:62-4.
        guideline and literature factors, patient barriers, resources, and organiza-  2.   Stec AA, Coons BJ, Chang SS, et al. Waiting time from initial urologi-
        tional/system factors. “Lack of radiologist experience in performing RTB”   cal consultation to nephrectomy for renal cell carcinoma — does it
        was a novel subtheme identified through this work. When considering   affect survival? J Urol 2008;179:2152-7. https://doi.org/10.1016/j.
        RTB facilitators, multidisciplinary teamwork facilitators, and institutional   juro.2008.01.111
        factors were the main themes. “Good interaction between different clini-  3.   Martínez CH, Martin P, Chalasani V, et al. How long can patients
        cians” was identified as a subtheme. The key recommended interventions   with renal cell carcinoma wait for surgery without compromising
        by urologists were resources for RTB, education on RTB, and guidelines   pathological outcomes? Can Urol Assoc J 2011;5:148-51. https://
        for RTB. A novel recommended intervention was “teach urologists to   doi.org/10.5489/cuaj.10035
        perform their own RTBs.”                             4.   Hyun Kim K, You D, Gab Jeong I, et al. The impact of delaying
        Conclusions: This research elucidated barriers not previously identified in   radical nephrectomy for stage II or higher renal cell carcinoma. J
        the literature. Barriers from the interviews, along with potential interven-  Cancer Res Clin Oncol 2012;138:1561-7. https://doi.org/10.1007/
        tions to overcome them, are currently being ranked by a panel of experts   s00432-012-1230-2
        to determine which intervention is the most appropriate to optimize the
        use of RTB in Ontario.
        S146                                    CUAJ • June 2019 • Volume 13, Issue 6(Suppl5)
   2   3   4   5   6   7   8   9   10   11